Vertex Pharmaceuticals Inc
Market cap $138.7B
$547.09
VRTX
$547.09
+0.85% today
Buy with €1M virtual cash · No real money
Vertex Pharmaceuticals Inc (VRTX) is a publicly traded company listed on the XNAS. As of November 8, 2026, Invest's signal rates VRTX a Hold. You can practice trading VRTX risk-free with €1,000,000 in virtual cash.
Key stats
As of November 8, 2026
Market Cap
$138.7B
Volume
1.3M
52-wk High
—
52-wk Low
—
Day High
$548.76
Day Low
$531.53
Performance
1M
+8.7%
VRTX overview
AI overviewLatest VRTX news
Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors
The Motley Fool · 18h ago
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
The Motley Fool · 20h ago
Sickle Cell Disease Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire Inc. · 4d ago
Vertex Q3 Earnings Call Highlights Revenue Beat and Pipeline Expansion
Zacks Investment Research · 4d ago
Breakfast News: Apple’s Record Quarter Has a Catch
The Motley Fool · 4d ago
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly).
Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).
Employees
6,400
30-Day Win Rate · VRTX
14 days
10 days
Last 24 sessions
How to practice trading VRTX
- 1
Use the VRTX buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top VRTX traders on Invest
Full leaderboardFrequently asked questions
Is VRTX a good stock to buy right now?
As of November 8, 2026, Invest's signal rates VRTX a Hold, based on its price trend, valuation, and fundamentals. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading VRTX risk-free first.
What is Vertex Pharmaceuticals Inc's (VRTX) market cap?
Vertex Pharmaceuticals Inc has a market capitalization of approximately $138.7B.
How has VRTX stock performed?
VRTX is actively traded. Its 52-week range runs roughly from — to —. Past performance doesn't predict future results.
How can I practice trading VRTX for free?
On Invest you get €1,000,000 in virtual cash and can buy VRTX at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare VRTX with peers